Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Trichomoniasis

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Bacterial Phylum Chlamydiae

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...

Microbiome of the Eye

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026

Same author

Prevalence of dual sensory impairment in Australia: a nationally representative population-based survey of Indigenous and non-Indigenous Australians.

The Lancet regional health. Western Pacific·2026

Same author

Health Economic Considerations for the Implementation of Artificial Intelligence-Enabled Diabetic Retinopathy Screening: A Review.

Clinical & experimental ophthalmology·2025

Same author

Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.

Journal of diabetes and metabolic disorders·2025

Same author

Prevalence of refractive error in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.

BMJ open ophthalmology·2025

Same author

Inherited retinal disease in global Indigenous populations: A scoping review.

Survey of ophthalmology·2025

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Search research articles

Video Experimental Relacionado

Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

El tracoma es un tracoma.

Heathcote R Wright¹, Angus Turner, Hugh R Taylor

¹Centre for Eye Research Australia, University of Melbourne, WHO Collaborating Centre for the Prevention of Blindness, East Melbourne, VIC, Australia. heathcote27@hotmail.com

Lancet (London, England)

|June 10, 2008

Resumen

Este resumen es generado por máquina.

La iniciativa de la Eliminación Global del Tracoma para 2020 tiene como objetivo erradicar el tracoma, una de las principales causas de ceguera prevenible. La estrategia SAFE (cirugía, antibióticos, limpieza facial, mejora ambiental) está demostrando ser eficaz en el control de esta enfermedad infecciosa ocular.

Más Videos Relacionados

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

Videos de Experimentos Relacionados

Last Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

Área de la Ciencia:

Oftalmología Oftalmología.
Enfermedades infecciosas Enfermedades infecciosas.
Salud Pública La salud pública.

Sus antecedentes:

El tracoma, una queratoconjuntivitis causada por Chlamydia trachomatis, conduce a la cicatrización y la ceguera.
El tracoma activo afecta a 84 millones de personas, de las cuales 1,3 millones son ciegas por la enfermedad en etapa terminal.
Las infecciones oculares repetidas causan cicatrización de la conjuntiva, distorsión de los párpados y abrasión de la córnea.

Objetivo del estudio:

Evaluar la efectividad de la iniciativa de la Eliminación Global del Tracoma para el año 2020.
Evaluar el impacto de la estrategia SAFE en el control y la eliminación del tracoma.
Proyectar la posible extinción del tracoma cegador para el año 2020.

Principales métodos:

Intervenciones a nivel comunitario basadas en la estrategia SAFE: cirugía para la triquiasis, antibióticos para el tracoma activo, limpieza facial y mejora ambiental.
Revisión de la evidencia que apoya las iniciativas de salud de la población.
Monitoreo de los esfuerzos globales hacia la eliminación del tracoma.

Principales resultados:

La estrategia SAFE demuestra su eficacia en el control del tracoma.
Los esfuerzos globales continuos son cruciales para lograr el objetivo de eliminación de 2020.
La evidencia apoya el enfoque para prevenir nuevos casos y ceguera.

Conclusiones:

El tracoma está al borde de la extinción debido a la iniciativa de la Eliminación Global del Tracoma para 2020.
La estrategia SAFE es un exitoso programa de salud pública para el control de enfermedades infecciosas oculares.
Se espera que la implementación sostenida de la estrategia SAFE elimine el tracoma cegador para 2020.